Luoxin Pharmaceuticals Group Stock Co., Ltd. (SZSE: 002793)
Health Care · Pharmaceuticals · CN
CN¥5.00
-5.48% today · -14.2% 1Y
Luoxin Pharmaceuticals Group Stock Co., Ltd. (SZSE: 002793) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $808.93M and employs 2,962 people.
Over the last twelve months the share price has lost 14.2%, trading between 3.70 and 6.04.
Tweenvest scores Luoxin Pharmaceuticals Group Stock Co., Ltd. across four factors: quality 56/100, value 45/100, growth 0/100. Its strongest factor is quality.
002793 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $808.93M
- Revenue (TTM)
- $345.02M
- P/E
- —
- EPS
- -0.24
- Dividend yield
- —
- Beta (5Y)
- 0.25
- 52-week high
- CN¥6.04
- 52-week low
- CN¥3.70
- Avg volume (3M)
- —
- Shares outstanding
- 1.09B
- Employees
- 2,962
- Next earnings
- —
About Luoxin Pharmaceuticals Group Stock Co., Ltd.
Luoxin Pharmaceuticals Group Stock Co., Ltd. is a Chinese pharmaceutical enterprise, primarily focused on the research, development, manufacture, and commercialization of pharmaceutical products. Headquartered in Linyi, the company offers an extensive portfolio of active pharmaceutical ingredients (APIs) and intermediates. These key components cater to a wide array of therapeutic areas, including antiviral and anti-infective treatments, respiratory and digestive system disorders, nervous and endocrine system conditions, cardiovascular health, oncology, and anti-allergy medications. Additionally, it supplies APIs and intermediates for antipyretic, analgesic, and anti-inflammatory drugs. Beyond its core pharmaceutical activities, Luoxin Pharmaceuticals also ventures into the provision of medical treatment and broader health services. The company adopted its current name, Luoxin Pharmaceuticals Group Stock Co., Ltd., in April 2020, having previously operated as Zhejiang Doyin Pump Industry Co., Ltd.
- Founded
- 1998
- Listed since
- Apr 15, 2016
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.